Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease
Read More
27 Jul 2020
UCB Half Year Report 2020: UCB’s resilient product portfolio drives continued company growth
Read More
24 Jul 2020
Disposals of own shares
Read More
24 Jul 2020
Bimekizumab Superior to Cosentyx[®] in Achieving Complete Psoriasis Skin Clearance
Read More
23 Jul 2020
Transparency notification FMR LLC.
Read More
17 Jul 2020
Disposals of own shares
Read More
10 Jul 2020
Disposals of own shares
Read More
7 Jul 2020
UCB and Ferring Pharmaceuticals Announce Co-Promotion of CIMZIA[®] (certolizumab pegol) for the Treatment of Adults with Moderate to Severe Crohn’s Disease
Read More
3 Jul 2020
Disposals of own shares
Read More
26 Jun 2020
Disposals of own shares
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
11
Page
12
Page
13
Page
14
Current page
15
Page
16
Page
17
Page
18
Page
19
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss